Evidence map›Paper›PMID 41920812›Full record

ArticlePloS one2026

Computational prediction of binding affinity and structural impact of three Pakistani SARS-CoV-2 spike RBD variants on human ACE2 interaction.

Muhammad Usama, Muhammad Azeem, Ghulam Mustafa

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Muhammad UsamaDepartment of Biochemistry, Government College University Faisalabad, Faisalabad Pakistan.ORCID https://orcid.org/0000-0001-6648-2450
Muhammad AzeemCollege of Life Sciences, Anhui Normal University, Wuhu, China.
Ghulam MustafaDepartment of Biochemistry, Government College University Faisalabad, Faisalabad Pakistan.ORCID https://orcid.org/0000-0001-6510-6496

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the current development and progress in vaccine synthesis, the transmission and infection rate of new variants of SARS-CoV-2 is still challenging in developing countries like Pakistan. Previous studies reported the transmission of new virus variants associated with the mutation in spike protein particularly in the receptor binding domain (RBD) of SARS-CoV-2 making RBD a promising target to control the infection rate. Any change in the spike RBD affects the interaction with host angiotensin-converting enzyme 2 (hACE2) receptor. These mutations in RBD assist SARS-CoV-2 entry in the host and enhance virulence and transmission rate. In the current study, we retrieved all substitution mutations in RBD of spike protein in three Pakistani SARS-CoV-2 variants from the GISAID database. Their structures were predicted via ColabFold2 and protein-protein docking was performed using HADDOCK. Interactions between docked complexes were checked by PyMOL and binding affinity (ΔG) (kcal/mol) was calculated via Prodigy server. The results of protein-protein interaction showed that the mutated hCoV-12471804 variant exhibited a higher number of interactions (202), low Z-score (-2.1), increased buried surface area (4066.4 ± 55.9), and high binding affinity (-21.3 kcal/mol) with hACE2 compared to hCoV-Wild variant. Moreover, the current study provides insights into the effects of mutations in RBD with hACE2 interaction providing deeper structural insight to understand the molecular mechanism responsible for the increased transmissibility of newly emerged SARS-CoV-2 variants. The exclusively in silico nature of this study necessitates experimental validation to definitively quantify the kinetic and thermodynamic parameters of the hACE2-RBD interaction.

Indexed as

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2Spike Glycoprotein, CoronavirusBinding SitesHumansMolecular Docking SimulationMutationPakistanProtein BindingACE2 protein, humanAngiotensin-Converting Enzyme 2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID41920812
PMCPMC13042742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.